ABVC (ABVC BioPharma) Earnings per share growth rate in current year
The annual growth rate of net income per share for ABVC BioPharma (ABVC) reflects an expansion phase of its plant-based drug portfolio for treating cancer and depression, with the value holding at 0.00. Alliances with Asian clinics to accelerate testing are driving this growth. High scalability derived from patents ensures low costs and market dominance following the certification of formulas.
Comprehensive metric breakdowns and analytics for ABVC BioPharma (ABVC)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Debt to Equity ABVC BioPharma|ABVC - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity abvcpharma.com|ABVC - Company Aggregate Debts|Debt to Book Value ABVC BioPharma, Inc|ABVC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings ABVC BioPharma|Quick Liquidity abvcpharma.com
- net income and valuation multiples indicators:
ABVC - Net Profit|Company Profit Forecast ABVC BioPharma|ABVC - Price to Earnings Ratio|Projected Price to Earnings Ratio ABVC BioPharma, Inc|ABVC - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio ABVC BioPharma, Inc|ABVC - Operating profit EBITDA|Earnings per share for the trailing year ABVC BioPharma|ABVC - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth abvcpharma.com|ABVC - Earnings per share growth in current year|Expected earnings per share trend next year ABVC BioPharma
Fundamental valuation:ABVC, ABVC BioPharma Inc.
Professional investors select resilient assets by comparing net profit growth rates with market valuation. This metric measures the percentage deviation of earnings per share from the previous year's figures. By analyzing year-over-year changes in EPS, one can identify discrepancies between yield and price. For ABVC BioPharma (ABVC), this price action confirms the commercialization of scientific developments. A rigorous approach to clinical trials of plant-based drugs ensures the stability of this fundamental trend.
Key competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal)|Earnings growth in current year Perrigo Company PLC PRGO|Alvotech Corp - Earnings growth in current year|LQDA: Earnings per share growth in current year|GLPG (Galapagos NV) - Net earnings per share growth this year|ANIP (anipharmaceuticals.com) - Earnings per share growth in current year|MNKD (MannKind) - Earnings growth in current year|Net earnings per share growth this year Amphastar Pharmaceuticals Inc (AMPH)|Net earnings per share growth this year PCRX (Pacira)|SPRY (ARS Corp) - Earnings per share increase in current year|Earnings growth in current year TBPH (Theravance Biopharma)|aquestive.com - Earnings per share growth in current year|scPharma - Earnings growth in current year|Expected net earnings per share growth this year Tectonic Therapeutic, Inc. TECX|Tonix Pharmaceuticals Inc. (TNXP) - Earnings per share growth in current year|Earnings per share growth rate in current year China SXT Pharmaceuticals, Inc. (SXTC)|Earnings per share growth in current year Eupraxia Pharmaceuticals, Inc.|bioharvest.com - Earnings per share trend in current year|Earnings growth in current year EXOZ|ORMP (oramed.com) - Earnings per share increase in current year|Earnings growth in current year ENTX (Entera Bio)|Earnings growth in current year MindWalk Therapeutics HYFT|CPIX - Earnings per share growth in current year|Earnings per share increase in current year QNTM (quantumbiopharma.com)|FibroGen (FGEN) - Earnings per share growth in current year|Net earnings per share growth this year Telomir Pharmaceuticals Inc|RANI (Rani Therapeutics Holdings) - Earnings growth in current year|Earnings growth in current year Synergy CHC Corporation|Earnings growth in current year RLYB|Earnings growth in current year lexariabioscience.com (LEXX)|Earnings growth in current year PULM (Pulmatrix)|Pheton Holdings Limited - Earnings per share growth in current year|APM: Net earnings per share growth this year|LYRA: Earnings per share growth in current year|IBO: Earnings growth in current year|Net earnings per share growth this year TNF Pharmaceuticals, Inc.|Earnings per share growth in current year cbdMD Inc.|PainReform Ltd - Earnings per share trend in current year|Earnings growth in current year CYTO|LIPO (Lipella Pharma) - Earnings per share increase in current year|Earnings growth in current year OPTN (OptiNose, Inc.)|Earnings growth in current year pieris.com PIRS|PROC - Earnings per share growth in current year|Earnings per share increase in current year PTPI (Petros Pharmaceuticals Inc)|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|Net earnings per share growth this year ACELYRIN Inc.|TFFP (TFF Pharmaceuticals) - Earnings growth in current year
